Democrats see drugmaker windfall from Medicare (Reuters)
Reuters - U.S. pharmaceutical companies
benefited from a $3.7 billion "windfall" during the first two
years of Medicare's prescription drug coverage, according to a
report from Democratic congressional staff released on
Thursday.